A
AtheroMed
Biotech & Life Sciences · Menlo Park, United States · Founded 2006
AtheroMed is engaged in developing the peripheral atherectomy catheter system to enhance the treatment of below the knee disease MoreLess
AtheroMed Inc. specializes in developing innovative medical devices aimed at treating peripheral artery disease (PAD), a condition characterized by narrowed arteries reducing blood flow to the limbs. The company's flagship product, the Phoenix Atherectomy System, is designed to remove plaque from blood vessels, thereby improving blood flow and reducing the risk of complications such as limb amputation. AtheroMed serves healthcare providers, including hospitals and specialized clinics, operating primarily in the medical device market. The business model revolves around the sale and distribution of its proprietary devices, generating revenue through direct sales and partnerships with medical institutions. The company leverages advanced technology to offer effective and minimally invasive solutions, positioning itself as a leader in the PAD treatment space.
Keywords: peripheral artery disease, medical devices, atherectomy, plaque removal, blood flow, healthcare providers, hospitals, clinics, advanced technology, minimally invasive.
Company overview
AtheroMed company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2006
- Headquarters
- Menlo Park, United States
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 18.0
Valuation & funding
AtheroMed funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | May 2014 | $117M | $117M | Volcano Corporation | — |
| DEBTDebt | Dec 2013 | $4.3M | — | Undisclosed | — |
| DEBT✓Debt | Apr 2013 | $6M | — | U.S. Venture Partners · Canaan · Kaiser Permanente Ventures · The Vertical Group | — |
| Other✓Other financing | Apr 2012 | $13M | — | The Vertical Group | — |
| DEBT✓Debt | May 2011 | $7.5M | — | Undisclosed | — |
| DEBT✓Debt | Dec 2009 | Undisclosed | — | ||
| SERIES A✓Equity / VC | Jan 2008 | U.S. Venture Partners | — |
Growth signals
AtheroMed website traffic
Latest recorded traffic for AtheroMed is 0 monthly website visits.
Comparisons
AtheroMed compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
AtheroMed's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where AtheroMed has talent and traffic
In the news
Latest news about AtheroMed
Recent press, funding announcements, and product moves mentioning AtheroMed — open to read from the original sources.
Market sentiment
What the market is saying about AtheroMed
An AI-synthesized read of the highest-engagement posts about AtheroMed on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AtheroMed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.